|Role of retroviral restriction factors in the interferon-α–mediated suppression of HIV-1 in vivo|
SK Pillai, M Abdel-Mohsen, J Guatelli, M Skasko, A Monto, K Fujimoto, ...
Proceedings of the National Academy of Sciences 109 (8), 3035-3040, 2012
|Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study|
SM Drescher, V von Wyl, WL Yang, J Böni, S Yerly, C Shah, V Aubert, ...
Clinical infectious diseases 58 (2), 285-294, 2014
|Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study|
G Wandeler, T Gsponer, F Bihl, E Bernasconi, M Cavassini, H Kovari, ...
The Journal of infectious diseases 208 (9), 1454-1458, 2013
|Acceptability of maternal immunization against influenza: the critical role of obstetricians|
G Blanchard-Rohner, S Meier, J Ryser, D Schaller, C Combescure, ...
The Journal of Maternal-Fetal & Neonatal Medicine 25 (9), 1800-1809, 2012
|Assessing the paradox between transmitted and acquired HIV type 1 drug resistance mutations in the Swiss HIV Cohort Study from 1998 to 2012|
WL Yang, R Kouyos, AU Scherrer, J Böni, C Shah, S Yerly, T Klimkait, ...
The Journal of infectious diseases 212 (1), 28-38, 2015
|Cultures familiales du risque|
|HIV-1 transmission during recent infection and during treatment interruptions as major drivers of new infections in the Swiss HIV Cohort Study|
A Marzel, M Shilaih, WL Yang, J Böni, S Yerly, T Klimkait, V Aubert, ...
Clinical Infectious Diseases 62 (1), 115-122, 2016
|Factors of change and cumulative factors in self-rated health trajectories: A systematic review|
S Cullati, E Rousseaux, A Gabadinho, DS Courvoisier, ...
Advances in Life Course Research 19, 14-27, 2014
|Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection|
KJ Metzner, AU Scherrer, B Preiswerk, B Joos, V von Wyl, C Leemann, ...
The Journal of infectious diseases 208 (7), 1102-1112, 2013
|Surveillance of risks in everyday life: The agency of pregnant women and its limitations|
Social theory & health 9 (4), 419-436, 2011
|A life course perspective on health trajectories and transitions|
C Burton-Jeangros, S Cullati, A Sacker, D Blane
|Tensions around risks in pregnancy: A typology of women's experiences of surveillance medicine|
RP Hammer, C Burton-Jeangros
Social Science & Medicine 93, 55-63, 2013
|Obesity trends and body mass index changes after starting antiretroviral treatment: The Swiss HIV Cohort Study|
B Hasse, M Iff, B Ledergerber, A Calmy, P Schmid, C Hauser, M Cavassini, ...
Open forum infectious diseases 1 (2), 2014
|Emergence of acquired HIV-1 drug resistance almost stopped in Switzerland: a 15-year prospective cohort analysis|
AU Scherrer, V von Wyl, WL Yang, RD Kouyos, J Böni, S Yerly, T Klimkait, ...
Clinical infectious diseases 62 (10), 1310-1317, 2016
|Strong impact of smoking on multimorbidity and cardiovascular risk among human immunodeficiency virus-infected individuals in comparison with the general population|
B Hasse, PE Tarr, P Marques-Vidal, G Waeber, M Preisig, V Mooser, ...
Open forum infectious diseases 2 (3), 2015
|Prostate cancer screening in Switzerland: 20-year trends and socioeconomic disparities|
I Guessous, S Cullati, SA Fedewa, C Burton-Jeangros, DS Courvoisier, ...
Preventive medicine 82, 83-91, 2016
|Colorectal cancer screening in Switzerland: cross-sectional trends (2007-2012) in socioeconomic disparities|
SA Fedewa, S Cullati, C Bouchardy, I Welle, C Burton-Jeangros, O Manor, ...
PloS one 10 (7), 2015
|Between tolerable uncertainty and unacceptable risks: how health professionals and pregnant women think about the probabilities generated by prenatal screening|
C Burton-Jeangros, S Cavalli, S Gouilhers, R Hammer
Health, risk & society 15 (2), 144-161, 2013
|Successful prevention of transmission of integrase resistance in the Swiss HIV Cohort Study|
AU Scherrer, WL Yang, RD Kouyos, J Böni, S Yerly, T Klimkait, V Aubert, ...
The Journal of infectious diseases 214 (3), 399-402, 2016
|Unresolved issues in risk communication research: the case of the H 1 N 1 pandemic (2009–2011)|
C Barrelet, M Bourrier, C Burton‐Jeangros, M Schindler
Influenza and other respiratory viruses 7, 114-119, 2013